Logout
Subscribe
62.1 F
Los Angeles
Wednesday, Apr 15, 2026
Logout
Subscribe
HomeHealth CareDrugs

Drugs

Health Care

New Sign-Off Propels ImmunityBio

Howard Fine -
Health Care

ImmunityBio, Xencor Drugs Win E.U. Nods

Howard Fine -
Health Care

Amgen Buys U.K. Biotech Company

Howard Fine -
Health Care

Arrowhead Hits the Mark

Howard Fine -
Health Care

City of Hope Dives Into Drug Trials

Howard Fine -
Health Care

Biotech Giant Amgen Will Expand Its R&D

Howard Fine -
Health Care

Arrowhead, Novartis Ink Agreement

Howard Fine -
Health Care

Atara Makes Second Try With FDA

Howard Fine -
Health Care

ImmunityBio Wins U.K. Approval

Howard Fine -
Health Care

Arrowhead Shares Bumpy After Partner Troubles

Howard Fine -
Health Care

GoodRx Has New Service For ED Meds

Howard Fine -
Health Care

Anktiva Approved For Additional Treatment

Howard Fine -
Health Care

FDA Delivers Blow to ImmunityBio

Howard Fine -
Health Care

NeOnc Sees Share Price Fall Since Going Public

Mark R. Madler -
Health Care

Acelyrin Sees Stock Price Rise Amid Rights Plan

Mark R. Madler -
Health Care

ImmunityBio Seeks Drug Approvals

Howard Fine -
Health Care

Atara Biotherapeutics Sees Its Share Price Fall

Mark R. Madler -
Health Care

Avita Gets FDA Nod For Device

Howard Fine -
Health Care

GoodRx Adds Pet Program

Howard Fine -
Health Care

Amgen Plans To Expand N.C. Campus

Howard Fine -
Health Care

GoodRx Taps Pharmacy Benefits Exec as CEO

Howard Fine -
Health Care

ImmunityBio Shares Plunge After Share Offering

Howard Fine -
Drugs

Arrowhead Pharma Shares See Big Price Jump

Mark R. Madler -
Health Care

Slew of New Drugs Sends Xencor Shares Soaring

Mark R. Madler -
Subscribe
Sign Up for Daily E-News Updates
Latest Articles

11150 Santa Monica Boulevard, Suite 350
Los Angeles, CA 90025
323-549-5225

Advertise with Us

About Us

Membership Center

Other Journals

© Los Angeles Business Journal